AlphAIAlphAI — Financial news for AI agents
SEC EDGARAUG 241 min read$NVST

Reis Mischa sold $220K of NVST

Reis Mischa (SVP, Strategy & Bus. Dev.) sold 8,000 shares of Envista Holdings Corp (NVST) at $27.50 ($0.22M total) on 2026-08-20 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Reis Mischa
Published Aug 24, 2026, 8:25 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 24, 2026, 9:04 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$NVST
Neutral
medium confidence
Mentioned
$NVST
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NVSTNeutralLow
01

Why it matters

While the transaction is modest, it provides transparency and may influence short‑term sentiment.

02

Market read

Routine insider sale with limited trading relevance.

03

What to watch

The 10b5‑1 plan pre‑arranges sales, reducing interpretive weight.

Relevance 3/10Novelty 2/10Timing: filed 2026-08-24

Background

Form 4 filings disclose insider transactions; a sale of $220K by a senior officer is publicly reported.

Company-level read

Ticker impact

$NVSTNeutralMedium confidence
Context

Officer Reis Mischa sold 8,000 shares for $220,000 via a 10b5‑1 plan, reducing his stake to 27,321 shares.

Expected impact

Potential modest dip in short term trading as market absorbs insider sell.

Evidence & confidence

Insider sales of this size are routine but can be interpreted as a weak negative signal.

Market effects

Sector

Minimal impact on the dental equipment sector.

Regional

No significant regional effect.

Global

Limited to investors tracking NVST.

Counterpoint

What could challenge this read

The sale could be a routine liquidity event, not a bearish signal.

Key entities

  • Company
    Envista Holdings Corp

    Dental equipment and services provider (ticker NVST).

  • Insider
    Reis Mischa

    SVP, Strategy & Business Development at Envista.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

NVST insider trading history →

Related articles

SEP 10
$NVSTMed

BMO reiterates Envista stock rating ahead of investor day

BMO Capital reiterated a Market Perform rating on Envista Holdings (NYSE:NVST) with a $29.00 price target, noting potential upside. The company showed 11.89% revenue growth over the last year, and 11 analysts revised earnings upwards. Envista recently beat Q2 2026 earnings and revenue estimates, raising its full-year outlook. JPMorgan upgraded the stock to Overweight with a $32.00 target, while Mizuho maintained a Neutral rating.

investing.com2 min
SEP 4
$NVSTHigh

Envista Holdings Shares Rise After JPMorgan Upgrade

Envista Holdings (NVST) shares rose 2.3% premarket after JPMorgan upgraded it to Overweight, raising the price target to $32 from $29. The upgrade comes ahead of Envista's Investor Day on September 17, with JPMorgan expecting improved execution and growth. The analyst anticipates a medium-term core growth range of 2.5% to 4.5%, citing resilient demand despite macroeconomic uncertainty.

yahoo.com2 min
SEP 3
$NVSTHigh

Why is Envista stock rallying today?

Envista (NVST) stock rose 2.3% pre-market after JPMorgan upgraded it to Overweight, raising its price target to $32. The bank cited improved execution, resilient demand, and attractive valuation. Envista's Q2 2026 results beat estimates, with adjusted EPS of $0.41 and revenue of $730.5M. The upgrade is ahead of the company's Investor Day on September 17.

investing.com1 min
SEP 3
$NVSTMed

Envista Holdings stock rises on JPMorgan upgrade

Envista Holdings (NVST) shares rose 2.3% premarket after JPMorgan upgraded them to Overweight with a $32 price target, up from $29. Analyst Lilia-Celine B Lozada cited improved execution, durable growth, and valuation not reflecting fundamentals. The upgrade comes ahead of the company's Investor Day on September 17.

investing.com2 min
AUG 14
$NVSTHighAI 9/10

Envista (NVST) Q2 2026 Earnings Call Transcript

Envista (NVST) reported Q2 2026 results on an earnings call, citing 5% core growth and sales of $731 million. Adjusted gross margin rose to 55.1%, adjusted EBITDA grew 28% with 14.7% margin, and adjusted EPS was $0.41 (+58%). Free cash flow was $105 million. The company raised 2026 guidance: core growth 3.5% to 4.5%, adjusted EBITDA 11% to 14%, adjusted EPS $1.50 to $1.55.

yahoo.com12 min